Quadrant Capital Group LLC Novo Cure LTD Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,199 shares of NVCR stock, worth $36,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,199

Previous 1,445 17.02%

Holding current value

$36,929

Previous $24,000 25.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.61 - $23.34 $3,840 - $5,741	-246 Reduced 17.02%	1,199 $18,000
Q2 2024 Aug 12, 2024	BUY	$11.83 - $24.05 $13,154 - $26,743	1,112 Added 333.93%	1,445 $24,000
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $1,453 - $2,022	117 Added 54.17%	333 $5,000
Q4 2023 Feb 08, 2024	BUY	$11.13 - $15.78 $756 - $1,073	68 Added 45.95%	216 $3,000
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $1,614 - $4,235	100 Added 208.33%	148 $2,000
Q2 2023 Aug 09, 2023	SELL	$40.29 - $82.51 $5,560 - $11,386	-138 Reduced 74.19%	48 $1,000
Q1 2023 May 11, 2023	SELL	$56.44 - $118.81 $4,571 - $9,623	-81 Reduced 30.34%	186 $11,000
Q4 2022 Feb 10, 2023	SELL	$63.98 - $85.37 $8,125 - $10,841	-127 Reduced 32.23%	267 $19,000
Q3 2022 Nov 10, 2022	SELL	$67.99 - $89.57 $3,807 - $5,015	-56 Reduced 12.44%	394 $30,000
Q2 2022 Aug 09, 2022	SELL	$56.6 - $89.9 $8,546 - $13,574	-151 Reduced 25.12%	450 $31,000
Q1 2022 May 06, 2022	BUY	$60.15 - $84.52 $23,037 - $32,371	383 Added 175.69%	601 $50,000
Q4 2021 Feb 01, 2022	BUY	$75.08 - $121.99 $12,538 - $20,372	167 Added 327.45%	218 $16,000
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $11,152 - $18,676	-96 Reduced 65.31%	51 $6,000
Q2 2021 Aug 09, 2021	BUY	$130.4 - $225.58 $9,780 - $16,918	75 Added 104.17%	147 $33,000
Q1 2021 May 12, 2021	BUY	$124.11 - $190.17 $8,067 - $12,361	65 Added 928.57%	72 $10,000
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $336 - $522	3 Added 75.0%	7 $1,000
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $232 - $445	4 New	4 $0
Q4 2019 Feb 03, 2020	SELL	$68.3 - $93.8 $5,190 - $7,128	-76 Closed	0 $0
Q3 2019 Oct 24, 2019	BUY	$61.86 - $97.8 $4,701 - $7,432	76 New	76 $5,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Novo Cure LTD Transaction History